Search En menu ClientConnect
Search
Results
Top 5 search results See all results Advanced search
Top searches
Most visited pages
    Reference: 20160727
    Release date: 5 September 2017

    Promoter – Financial Intermediary

    HUVEPHARMA INTERNATIONAL BV

    Location

    Description

    The project consists of the construction of new manufacturing facilities, as well as financing of the promoter's research, development and innovation (RDI) activities.

    Objectives

    The EIB loan will be supporting the capacity expansion of a mid-cap company in Bulgaria.

    Sector(s)

    Proposed EIB finance (Approximate amount)

    EUR 125 million

    Total cost (Approximate amount)

    EUR 212 million

    Environmental aspects

    The project falls under Annex II of EIA Directive 2011/92/EU (implementation of an industrial facility for the production of pharmaceutical products). Full environmental details will be assessed during the appraisal.

    Procurement

    The promoter is a private company not operating in the utilities sector and is thus not covered by EU directives on procurement.

    Status

    Signed - 22/12/2017

    Disclaimer

    Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The data provided on this page is therefore indicative and cannot be considered to represent official EIB policy (see also the Explanatory notes).

    Related tags

    Bulgaria Industry